Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor
NCT02555982Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jun 2016
- Primary completion
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in essential tremor (ET), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started Jun 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on NCT02555982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02555982.